Multiple myeloma causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
(4 intermediate revisions by one other user not shown) | |||
Line 9: | Line 9: | ||
===Common causes=== | ===Common causes=== | ||
The causes of multiple myeloma include: | The causes of multiple myeloma include: | ||
*Mutations in the tumor suppressor ''TP53'' (most common) | |||
*Sporadic mutations and genetic predisposition | *Sporadic mutations and genetic predisposition | ||
*Mutations in tumor suppressors or oncogenes | *Mutations in tumor suppressors or oncogenes | ||
*Chromosomal aberrations such as translocations can trigger the onset of malignancy and allow for uncontrolled plasma cell proliferation.<ref name="pmid27291302">{{cite journal| author=Rajkumar SV| title=Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. | journal=Am J Hematol | year= 2016 | volume= 91 | issue= 7 | pages= 719-34 | pmid=27291302 | doi=10.1002/ajh.24402 | pmc=5291298 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27291302 }} </ref> | *Chromosomal aberrations such as translocations can trigger the onset of malignancy and allow for uncontrolled plasma cell proliferation.<ref name="pmid27291302">{{cite journal| author=Rajkumar SV| title=Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. | journal=Am J Hematol | year= 2016 | volume= 91 | issue= 7 | pages= 719-34 | pmid=27291302 | doi=10.1002/ajh.24402 | pmc=5291298 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27291302 }} </ref> | ||
===Less common causes=== | ===Less common causes=== | ||
* Familial causes are less contributory to the development of multiple myeloma compared to sporadic causes.<ref name="pmid27291302">{{cite journal| author=Rajkumar SV| title=Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. | journal=Am J Hematol | year= 2016 | volume= 91 | issue= 7 | pages= 719-34 | pmid=27291302 | doi=10.1002/ajh.24402 | pmc=5291298 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27291302 }} </ref> | * Familial causes are less contributory to the development of multiple myeloma compared to sporadic causes.<ref name="pmid27291302">{{cite journal| author=Rajkumar SV| title=Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. | journal=Am J Hematol | year= 2016 | volume= 91 | issue= 7 | pages= 719-34 | pmid=27291302 | doi=10.1002/ajh.24402 | pmc=5291298 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27291302 }} </ref> | ||
===Causes by Organ System=== | |||
{| style="width:80%; height:100px" border="1" | |||
| style="width:25%" bgcolor="LightSteelBlue" ; border="1" |'''Cardiovascular''' | |||
| style="width:75%" bgcolor="Beige" ; border="1" | No underlying causes | |||
|- | |||
| bgcolor="LightSteelBlue" | '''Chemical/Poisoning''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Dental''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Dermatologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Drug Side Effect''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Ear Nose Throat''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Endocrine''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Environmental''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Gastroenterologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Genetic''' | |||
| bgcolor="Beige" |Mutations in the tumor suppressor ''TP53, s''poradic mutations and genetic predisposition, mutations in tumor suppressors or oncogenes, chromosomal aberrations such as translocations, familial inheritance | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Hematologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Iatrogenic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Infectious Disease''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Musculoskeletal/Orthopedic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Neurologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Nutritional/Metabolic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Obstetric/Gynecologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Oncologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Ophthalmologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Overdose/Toxicity''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Psychiatric''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Pulmonary''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Renal/Electrolyte''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Rheumatology/Immunology/Allergy''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Sexual''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Trauma''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Urologic''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|- bgcolor="LightSteelBlue" | |||
| '''Miscellaneous''' | |||
| bgcolor="Beige" | No underlying causes | |||
|- | |||
|} | |||
===Causes in Alphabetical Order=== | |||
List the causes of the multiple myeloma in alphabetical order: | |||
<div style="-moz-column-count:3; column-count:3;"> | |||
* Chromosomal aberrations | |||
* Familial inheritance | |||
* Mutations in oncogenes | |||
* Mutations in the tumor suppressor TP53 | |||
* Mutations in tumor suppressors | |||
* Translocations | |||
</div> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Line 23: | Line 151: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Surgery]] | [[Category:Surgery]] |
Latest revision as of 22:46, 29 July 2020
Multiple myeloma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Multiple myeloma causes On the Web |
American Roentgen Ray Society Images of Multiple myeloma causes |
Risk calculators and risk factors for Multiple myeloma causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Shyam Patel [3]
Overview
The causes of multiple myeloma include sporadic mutations, such as TP53 mutation, and inherited predisposition.
Causes
Common causes
The causes of multiple myeloma include:
- Mutations in the tumor suppressor TP53 (most common)
- Sporadic mutations and genetic predisposition
- Mutations in tumor suppressors or oncogenes
- Chromosomal aberrations such as translocations can trigger the onset of malignancy and allow for uncontrolled plasma cell proliferation.[1]
Less common causes
- Familial causes are less contributory to the development of multiple myeloma compared to sporadic causes.[1]
Causes by Organ System
Cardiovascular | No underlying causes |
Chemical/Poisoning | No underlying causes |
Dental | No underlying causes |
Dermatologic | No underlying causes |
Drug Side Effect | No underlying causes |
Ear Nose Throat | No underlying causes |
Endocrine | No underlying causes |
Environmental | No underlying causes |
Gastroenterologic | No underlying causes |
Genetic | Mutations in the tumor suppressor TP53, sporadic mutations and genetic predisposition, mutations in tumor suppressors or oncogenes, chromosomal aberrations such as translocations, familial inheritance |
Hematologic | No underlying causes |
Iatrogenic | No underlying causes |
Infectious Disease | No underlying causes |
Musculoskeletal/Orthopedic | No underlying causes |
Neurologic | No underlying causes |
Nutritional/Metabolic | No underlying causes |
Obstetric/Gynecologic | No underlying causes |
Oncologic | No underlying causes |
Ophthalmologic | No underlying causes |
Overdose/Toxicity | No underlying causes |
Psychiatric | No underlying causes |
Pulmonary | No underlying causes |
Renal/Electrolyte | No underlying causes |
Rheumatology/Immunology/Allergy | No underlying causes |
Sexual | No underlying causes |
Trauma | No underlying causes |
Urologic | No underlying causes |
Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List the causes of the multiple myeloma in alphabetical order:
- Chromosomal aberrations
- Familial inheritance
- Mutations in oncogenes
- Mutations in the tumor suppressor TP53
- Mutations in tumor suppressors
- Translocations
References
- ↑ 1.0 1.1 Rajkumar SV (2016). "Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management". Am J Hematol. 91 (7): 719–34. doi:10.1002/ajh.24402. PMC 5291298. PMID 27291302.